CoQ10 may interact with certain medications, causing side effects or making them less effective. Find out if you shouldn't ...

ELIQUIS demonstrated non-inferiority (p<0.001) for the primary efficacy outcome, composite of stroke or systemic embolism, compared with warfarin.

Conclusions In patients with atrial fibrillation, apixaban was superior to warfarin in preventing stroke or systemic embolism, caused less bleeding, and resulted in lower mortality.

In A Subanalysis, The Benefits Of Eliquis® (apixaban) Vs. Warfarin In Reducing The Risk Of Stroke In Patients With Nonvalvular Atrial Fibrillation Were Consistent, Regardless Of Blood Pressure ...

The blood clot preventer Eliquis, sold by Pfizer Inc and Bristol-Myers Squibb Co, proved as effective as widely used warfarin in treating a dangerous condition known as venous thromboembolism and ...

The benefits of apixaban on stroke/systemic embolism and all-cause death vs. warfarin are similar in patients with and without peripheral artery disease (PAD), but a greater reduction in bleeding ...

PARIS, France—Apixaban, an oral direct factor Xa inhibitor, is the latest novel anticoagulant to prove superior to warfarin for preventing stroke or systemic embolism in patients with atrial ...

Eliquis is a prescription drug used to treat or help prevent certain kinds of blood clots. Discover drug interactions in depth, when to avoid Eliquis, and more.

A large-scale trial finds that apixaban, a new anticoagulant drug, is superior to the standard drug warfarin for preventing stroke.

In patients with venous thromboembolism (VTE) who are candidates for oral anticoagulation, apixaban results in fewer hospitalizations for recurrence and less major bleeding than rivaroxaban or ...

ELIQUIS® (apixaban) was Superior to Warfarin for the Reduction of Stroke or Systemic Embolism with Significantly Less Major Bleeding in Patients with Atrial Fibrillation in Phase 3 ARISTOTLE ...

ARISTOTLE Demonstrated that ELIQUIS is the First Oral Anticoagulant to Significantly Reduce All-Cause Death ELIQUIS, Compared to Standard of Care Warfarin, Significantly Reduced:Risk of stroke or ...